Pardes Biosciences Statistics Share Statistics Pardes Biosciences has 62.01M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 62.01M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 14.06M Failed to Deliver (FTD) Shares 179,735 FTD / Avg. Volume 35.26%
Short Selling Information The latest short interest is 18.36K, so 0% of the outstanding
shares have been sold short.
Short Interest 18.36K Short % of Shares Out n/a Short % of Float 0.05% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.05 and the forward
PE ratio is null.
Pardes Biosciences's PEG ratio is
-0.01.
PE Ratio -1.05 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.55 P/FCF Ratio -1.36 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pardes Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.81,
with a Debt / Equity ratio of 0.
Current Ratio 9.81 Quick Ratio 9.81 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -31.36
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.64M Employee Count 57 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.18M Effective Tax Rate 3.29%
Stock Price Statistics The stock price has increased by 0.93% in the
last 52 weeks. The beta is 0.42, so Pardes Biosciences's
price volatility has been higher than the market average.
Beta 0.42 52-Week Price Change 0.93% 50-Day Moving Average 2.07 200-Day Moving Average 1.74 Relative Strength Index (RSI) 70.03 Average Volume (20 Days) 509,687
Income Statement
Revenue n/a Gross Profit n/a Operating Income -99.82M Net Income -93.45M EBITDA -93.45M EBIT -93.45M Earnings Per Share (EPS) -1.61
Full Income Statement Balance Sheet The company has 59.28M in cash and 0 in
debt, giving a net cash position of 59.28M.
Cash & Cash Equivalents 59.28M Total Debt n/a Net Cash n/a Retained Earnings -148.16M Total Assets 157.31M Working Capital 155.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -71.98M
and capital expenditures 0, giving a free cash flow of -71.98M.
Operating Cash Flow -71.98M Capital Expenditures n/a Free Cash Flow -71.98M FCF Per Share -1.24
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
